Arbutus Biopharma Corp (ABUS) Stock Price & Analysis
Arbutus Biopharma Corp (ABUS) rose 0.59% to USD 5.15 as of September 8, 2026 at 08:18 UTC, according to Nexqual real-time market data.
ABUS last closed at USD 5.15; the session ranged USD 5.09–5.17 on volume of 5,198,303 shares. Market capitalization is —, with a 52-week range of USD 3.5–5.45 (NMS). Source: Nexqual, September 8, 2026 at 08:18 UTC.
Key Statistics (as of September 8, 2026 at 08:18 UTC)
| Price | USD 5.15 |
|---|---|
| Change | ▲ 0.59% (up) |
| Previous Close | USD 5.15 |
| Open | USD 5.15 |
| Day Range | USD 5.09 – 5.17 |
| 52-Week Range | USD 3.5 – 5.45 |
| Volume | 5,198,303 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ABUS)
Nexqual's technical model rates ABUS "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 08:18 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 63.37 (neutral) |
| vs SMA50 | Above (USD 4.75) |
| MACD | 0.14 (positive) |
From Arbutus Biopharma Corp's Latest SEC 10-K Filing (filed 2026-03-23)
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ALDX | Aldeyra Therapeutics, Inc. | USD 1.48 | ▼ 0.67% |
| ABEO | Abeona Therapeutics Inc. | USD 6 | ▲ 0.84% |
| CRVS | Corvus Pharmaceuticals, Inc. | USD 14.39 | ▲ 1.34% |
| ADMA | ADMA Biologics Inc | USD 9.62 | ▲ 1.16% |
| AFMDQ | Affimed N.V. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 08:18 UTC. This page is informational and not investment advice.